Dr. Gang Li 李刚
Chief Physician, Associate Professor
Department of General Surgery, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of gastric malignancies, including gastric cancer and gastrointestinal stromal tumors. Specializes in robotic and laparoscopic gastric surgery.
Dr. Li holds a medical degree from Nanjing University Medical School and serves as a Chief Physician, Associate Professor, and master’s supervisor. In 2012, Dr. Li completed a one-year fellowship in the United States. Dr. Li has led multiple national and provincial research projects and published over ten medical papers.
Name order: in Chinese the family name comes first (Li Gang). Papers usually list the name as Gang Li or Li G.
Selected publications
60 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Drug Resist Updat, 2026 (senior author): Corrigendum to "RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress" [Drug Resist. Updat. 86 (2026) 101375]. PubMed 42034474
- Drug Resist Updat, 2026 (senior author): RNF26 regulating tumor immunogenicity of hepatocellular carcinoma by degrading GRP78 and instigating ER stress. PubMed 41687462
- Neurooncol Adv, 2026 (first author): An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma. PubMed 42211392
- JMIR Res Protoc, 2026 (senior author): Tunnel Anastomosis vs Double-Tract Jejunal Interposition Reconstruction After Proximal Gastrectomy: Protocol for a Multicenter Prospective Randomized Controlled Trial. PubMed 41894519
- Front Oncol, 2026 (senior author): Case Report: A successfully managed case of SMARCA4-deficient undifferentiated gastric carcinoma. PubMed 41815546
- Drug Resist Updat, 2025 (senior author): N6-methyladenosine modification of 3'tRF-AlaAGC impairs PD-1 blockade efficacy by promoting lactic acid accumulation in the tumor microenvironment of gastric carcinoma. PubMed 39752904
- J Gastrointest Surg, 2025 (senior author): Tunnel anastomosis: a modified flap technique in esophagogastrostomy as a novel antireflux technique after proximal gastrectomy. PubMed 39490562
- J Clin Lab Anal, 2020 (senior author): Hsa_circ_0023642 promotes proliferation, invasion, and migration of gastric cancer by sponging microRNA-223. PubMed 32562304
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers; we checked the papers' affiliations and topics against this doctor's department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion